No Picture
Trading Ideas

3 Types of Securities Investments Explained

Investing can be a great way to make money. But there is more than one way to invest. There are a few different types of securities you can put your money into, each with their own risks and benefits. By understanding the securities you can invest in, you’ll have a better idea of where you want to put your money.
What Is a Security?
Securities are financial instruments that can be traded on financial exchanges. There are exchanges around the world such as Nasdaq, Euronext, and, maybe the most famous, the New York Stock Exchange (NYSE).
Securities can be broken down into three …read more […]

No Picture
Trading Ideas

Types of Investment Funds

What is an Investment Fund?
An investment fund pools together capital from many investors. Each investor has partial ownership and the fund invests according to the fund’s objectives. Investment funds offer a wide range of investment opportunities. They can also benefit from diversification, lower transaction costs and management expertise. This can help mitigate some of the risk that individual investors take on.

Types of Investment Funds:

Open-End vs Closed-End Funds
Mutual Funds
ETFs
Hedge Funds
Index Funds

These fund types serve similar purposes, fundamentally. They allow you to invest in a diversified portfolio of assets that you might not otherwise be able to gather yourself. But it’s important …read more […]

No Picture
Trading Ideas

Drugmakers slash prices to be eligible for China's bulk-buy program

Global pharmaceutical majors and generic drugmakers chopped by 53% on average prices of some of their off-patent products in the latest bidding round under China’s national bulk-buy program, government officials said late on Friday. Beijing has been pushing forward the program where drugmakers have to go through a bidding process and cut prices low enough to be considered over generic copies and be allowed to sell their products at public hospitals via large-volume government procurement. Some global firms such as AstraZeneca and Merck have already cautioned about intensifying price pressures on their mature brands in the world’s second …read more […]